Dl. Reynolds et Ad. Maraqa, A technique for inducing B-cell ablation in chickens by in ovo injection of cyclophosphamide, AVIAN DIS, 43(3), 1999, pp. 367-375
The effect of cyclophosphamide (CY) treatment in ovo on avian B and T cells
was studied. CY was injected in ovo on the 16th, 17th, and 18th days of in
cubation. Blood samples were collected periodically from CY-treated and non
treated birds after hatch and were used to measure blood lymphocyte respons
es to the T-cell and B-cell mitogens, concanavalin A and lipopolysaccharide
(LPS), respectively. Additionally, flow cytometric analysis was used to de
termine the presence of B and T cells in peripheral blood, and birds were v
accinated with Newcastle disease virus (NDV) antigen at 3 wk of age and boo
ster vaccinated at 5 wk of age. CY treatment reduced hatchability by 35%-40
%, increased mortality by 3%-5% within the first 2 wk of life, and induced
a significant retardation in body weight gains. At 2 wk of age, approximate
ly 50% of CY-treated birds were devoid of B-cell mitogenic responsiveness w
hile demonstrating significant T-cell mitogenic responsiveness. However, B-
cel; responses were observed at 4 and 6 wk from a small percentage of birds
that were originally T-cell responsive and B-cell nonresponsive at 2 wk of
age. Flow cytometric analysis of peripheral blood lymphocytes revealed tha
t CY-treated birds had significantly less B-cells (or were devoid of B cell
s) than the corresponding nontreated control birds. However, no significant
difference in the T-cell percentage was observed between CY-treated and no
ntreated birds.
CY-treated birds did not produce detectable antibodies specific for NDV dur
ing the first and second weeks postvaccination, as demonstrated by hemagglu
tination inhibition assay. However, antibodies were detected in some CY-tre
ated birds 10 days postbooster. Those antibody-positive birds were found to
be the same birds that had subsequently responded to the LPS mitogen on th
e blastogenesis microassay. This study indicates the importance of monitori
ng the B- and T-cell responses in CY-treated birds to identify those birds
in which B-cell regeneration may have occurred.